Jeff Sharman, MD Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, discusses The CLL-14 Studies Importance In Determining CLL Treatment Strategies. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com